Navigation Links
BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial
Date:7/17/2008

- Second instance where survival increase is observed in advanced non-small cell lung cancer patients receiving Tavocept in conjunction with standard

chemotherapy

- Median survival increase of 6.5 months seen for patients with

adenocarcinoma, the most common type of lung cancer

SAN ANTONIO, July 17 /PRNewswire/ -- BioNumerik Pharmaceuticals, Inc. ("BioNumerik") today announced that patients with adenocarcinoma (the most frequently occurring form of lung cancer) participating in a Phase II clinical trial of Tavocept(TM) showed a survival increase of approximately 198 days (6.5 months). The trial observations included an approximate 40% reduction in mortality for adenocarcinoma patients receiving Tavocept. The percentage of adenocarcinoma patients in the Tavocept group who were alive after 12 months (One-year survival) was 58% compared to 37% for adenocarcinoma patients in the chemotherapy only group. The median survival time for all non-small cell lung cancer (NSCLC) patients in the trial showed an increase of approximately one month for patients receiving Tavocept. This is the second Tavocept clinical trial where this pattern of survival increase has been observed. Tavocept is an investigational new drug with potential for oncology and non-oncology indications that was originated and developed by BioNumerik.

The randomized Phase II clinical trial (the "U.S. Tavocept Trial") was performed at multiple sites in the U.S. and involved 151 patients with advanced NSCLC who received the chemotherapy drugs docetaxel (sold under the brand name Taxotere(R)) and cisplatin every two weeks. Approximately half of the patients received Tavocept along with chemotherapy, while the other half received chemotherapy alone.

Additional observations from the U.S. Tavocept Trial included a lower level of treatment discontinuation due to adverse events for the Tavocept group as well as a lower frequency of serio
'/>"/>

SOURCE BioNumerik Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioNumerik Pharmaceuticals and ASKA Pharmaceutical Co. Announce Results from Phase III Clinical Trial of Tavocept(TM)
2. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
6. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
7. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
8. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
9. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
10. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
11. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Medina Medical announced ... and member of the Board of Directors on August ... device development and commercialization experience, including over a decade ... previously served as a Partner of the medical device ... CEO of two Foundry start-ups. Mr. Engelson previously served ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Development Trend Forecast of Pharmaceutical Equipment Market in China, ... Research and Development Trend Forecast of Pharmaceutical Equipment Market ... China,s pharmaceutical equipment industry in ... competition landscape, and business performance of domestic major enterprises, ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
(Date:8/31/2014)... September 01, 2014 Recently, BambooIndustry.com, one of ... website with a new selection of bamboo veneers . ... 25 percent off) for these high quality products. The promotion ... company’s senior spokesman says that its top quality veneers are ... unveil the new designs of bamboo veneers. All these items ...
(Date:8/31/2014)... In order to celebrate the coming of autumn, Guangdong ... and launched a big promotion. Now, all the global clients ... company’s new cars are made with great materials. FODAY Automobile ... As a matter of fact, it is providing big discounts ... in need of cheap cars can visit its website for ...
(Date:8/31/2014)... 1Heart Caregiver Services Director for Business Development ... Tee Barr conducted a brain fitness education lecture at ... Ayala and Social Services designee Lily are both appreciative ... fitness session. , Research studies have found that cognitive ... of dementia and memory loss. The six essential areas ...
(Date:8/31/2014)... Louis (PRWEB) August 31, 2014 Twin to ... twins Aiden and Blake Colp before they were born, but an ... Institute gave them the chance at life. , Now, their ... and the life-saving fetal surgery option available in St. Louis at ... awareness nights at Market Pub House (6655 Delmar Blvd, St ...
(Date:8/31/2014)... Ticket Down is a dependable source for authentic ... in suburban Denver. The Mexican national soccer team ... teams on USA soil. , Prior to ... aboard, Miguel Herrera, and he has had excellent results with ... in Brazil, the Mexican team played quite well and continued ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Veneers from Bambooindustry.com Receive International Attention 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 2Health News:After a Rare Diagnosis Threatened Their Boys’ Lives, Parents Build Awareness About TTTS and Fetal Surgery Options at The SSM St. Louis Fetal Care Institute. 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 3
... , TUESDAY, Dec. 7 (HealthDay News) -- Stool tests that ... patients on a low-dose aspirin regimen, which is known to ... therapeutic aspirin use was once feared to skew the results ... the test was significantly more sensitive for low-dose aspirin users ...
... be a life saver for patients needing immediate care. ... process of activating them often delays treatment beyond recommended ... in Annals of Emergency Medicine, was led ... retrospective chart review, McMullan found that a majority of ...
... In an effort to pinpoint potential triggers leading to inflammatory ... close look at the immune system of people living in ... people have steadily grown to outnumber rates of depression in ... of a loss of healthy bacteria. In an article ...
... Occlusion Summit and Left Main Coronary Interventions Course ... findings and new developments in therapeutic procedures essential ... total coronary occlusions and left main coronary interventions. ... When and why to open a chronic total ...
... HealthDay Reporter , TUESDAY, Dec. 7 (HealthDay News) ... the best way to help such veterans stop smoking, a ... researchers randomly assigned 943 smokers with PTSD from their wartime ... and its participants were referred to a VA smoking ...
... By Ellin Holohan HealthDay Reporter , TUESDAY, ... become rampant in the United States, with emergency departments ... injuries, safety experts reported Tuesday. As more children ... suffering an ever-increasing number of injuries, the experts from ...
Cached Medicine News:Health News:Low-Dose Aspirin Boosts Accuracy of Colon Cancer Test 2Health News:Low-Dose Aspirin Boosts Accuracy of Colon Cancer Test 3Health News:Even with helicopter EMS, hospital transfer can delay treatment for heart attacks 2Health News:Even with helicopter EMS, hospital transfer can delay treatment for heart attacks 3Health News:CTO Summit & Left Main Coronary Interventions Course to be held Feb. 14-16, 2011, in NYC 2Health News:Treating PTSD and Smoking Together Best Way to Help Vets Kick Cigarettes 2Health News:Treating PTSD and Smoking Together Best Way to Help Vets Kick Cigarettes 3Health News:Youth Sports Injuries Reaching Epidemic Levels, Experts Report 2Health News:Youth Sports Injuries Reaching Epidemic Levels, Experts Report 3
Straight shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Colibri style tips. Double toothed tips with 0.10 mm teeth spaced 1 mm apart and 7 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with teeth and 6 mm crisscross serrated tying surfaces. Serrated handle with polished finish....
Serrated, 10 mm tips angled 30 degrees. Serrated cross action handle with polished finish....
Medicine Products: